000 | 01859 a2200505 4500 | ||
---|---|---|---|
005 | 20250515183803.0 | ||
264 | 0 | _c20100105 | |
008 | 201001s 0 0 eng d | ||
022 | _a1878-1705 | ||
024 | 7 |
_a10.1016/j.intimp.2009.08.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMuraki, Masato | |
245 | 0 | 0 |
_aInhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication. _h[electronic resource] |
260 |
_bInternational immunopharmacology _cOct 2009 |
||
300 |
_a1337-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcetates _xadministration & dosage |
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAsthma _xchemically induced |
650 | 0 | 4 |
_aBronchial Hyperreactivity _xchemically induced |
650 | 0 | 4 |
_aBronchoconstriction _xdrug effects |
650 | 0 | 4 | _aCyclopropanes |
650 | 0 | 4 |
_aCysteine _xantagonists & inhibitors |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aImmunologic Factors _xantagonists & inhibitors |
650 | 0 | 4 |
_aLeukotriene Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aLeukotriene C4 _xpharmacology |
650 | 0 | 4 |
_aLeukotriene D4 _xpharmacology |
650 | 0 | 4 |
_aLeukotrienes _xpharmacology |
650 | 0 | 4 |
_aLung _xanatomy & histology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOvalbumin _ximmunology |
650 | 0 | 4 |
_aQuinolines _xadministration & dosage |
650 | 0 | 4 | _aSulfides |
700 | 1 | _aImbe, Shu | |
700 | 1 | _aSato, Ryuji | |
700 | 1 | _aIkeda, Yoko | |
700 | 1 | _aYamagata, Shigeyoshi | |
700 | 1 | _aIwanaga, Takashi | |
700 | 1 | _aTohda, Yuji | |
773 | 0 |
_tInternational immunopharmacology _gvol. 9 _gno. 11 _gp. 1337-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2009.08.007 _zAvailable from publisher's website |
999 |
_c19108097 _d19108097 |